Page 27 - 2017食品藥物管理署年報(英文版)
P. 27
2017 Taiwan Food and Drug Administration Annual Report Chapter 2. Legal Environment and Registration
Table 2-4 Revisions to Controlled Drug Schedules in 2016
Date of Promulgate the names of
amendment Schedules the controlled drugs Descriptions
A central nervous system
3,4-methylenedioxy-N-ethylcathinone,
March 25 Schedule 3 stimulant with MDMA-like
Ethylone
effects. No therapeutic effects.
Has structures similar to
2-(3-methoxyphenyl)-2-(ethylamin
March 25 Schedule 3 ketamine, addictive and
o) cyclohexanone, Methoxetamine, MXE
produces hallucination.
Chloromethcathinone (CMC), including
2-Chloromethcathinone (2-CMC),
March 25 Schedule 3 3-Chloromethcathinone (3-CMC) and A central nervous stimulant. No
4-Chloromethcathinone (4-CMC) three therapeutic effects.
position isomers
Bromomethcathinone (BMC), including
2-Bromomethcathinone(2-BMC),
March 25 Schedule 3 3-Bromomethcathinone (3-BMC) and A central nervous stimulant. No
4-Bromomethcathinone therapeutic effects.
(4-BMC) three position isomers
Total 310
Schedule 1 9
Schedule 2 179
Schedule 3 42
Schedule 4 73
7
Figure 2-3 Statistics on the number of controlled
drugs in each schedule as of 2016
25
